Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenus
37
27
55
55
56
50
Croissance des revenus (H/H)
3%
-51%
0%
-2%
12%
-18%
Coût des ventes
16
16
18
17
17
18
Bénéfice brut
21
11
37
37
39
31
Vente, Général et Administration
35
35
38
36
35
37
Recherche et développement
--
--
--
--
--
--
Frais d'exploitation
35
35
37
35
34
37
Autres revenus (charges) non opérationnels
--
--
--
--
--
--
Bénéfice avant impôts
-9
-18
4
5
7
7
Charge d'impôt sur le revenu
1
0
0
0
0
1
Bénéfice net
-11
-18
3
4
6
6
Croissance du bénéfice net
0%
-700%
-25%
-33%
0%
0%
Actions en circulation (diluées)
256.3
256.3
256.29
255.74
256.23
256.37
Variation des actions (H-H)
0%
0%
0%
0%
0%
1%
EPS (dilué)
-0.04
-0.07
0.01
0.01
0.02
0.02
Croissance du EPS
0%
-634%
-28%
-20%
-6%
0%
Flux de trésorerie libre
-9
-14
6
3
7
14
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
56.75%
40.74%
67.27%
67.27%
69.64%
62%
Marge opérationnelle
-37.83%
-88.88%
0%
1.81%
7.14%
-10%
Marge bénéficiaire
-29.72%
-66.66%
5.45%
7.27%
10.71%
12%
Marge du flux de trésorerie libre
-24.32%
-51.85%
10.9%
5.45%
12.5%
28%
EBITDA
-10
-20
4
4
7
-1
Marge EBITDA
-27.02%
-74.07%
7.27%
7.27%
12.5%
-2%
D&A pour le résultat opérationnel
4
4
4
3
3
4
EBIT
-14
-24
0
1
4
-5
Marge EBIT
-37.83%
-88.88%
0%
1.81%
7.14%
-10%
Taux d'imposition effectif
-11.11%
0%
0%
0%
0%
14.28%
Statistiques clés
Clôture préc.
$0.0689
Prix d'ouverture
$0.1018
Plage de la journée
$0.0689 - $0.1018
Plage de 52 semaines
$0.0689 - $0.1722
Volume
2.1K
Volume moyen
180
BPA (TTM)
-0.04
Rendement en dividend
--
Capitalisation boursière
$17.6M
Qu’est-ce que CORDLIFE GROUP LIMITED ?
Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood and cord lining banking services. The firm's principal activities involve investment holding and the provision of cord blood banking services. Its segments include Banking and Diagnostics. The Banking segment comprises of the banking of samples such as cord blood, cord lining and cord tissue. Cord blood, cord lining and cord tissue are collected, processed, and stored in the various laboratories. The Diagnostics segment comprises diagnostic testing such as non-invasive prenatal testing service, newborn metabolic screening, newborn genetic screening, and pediatric vision screening services. Its subsidiaries include Cordlife (Hong Kong) Limited, Cordlife Stem Cell Technology Limited, Healthbaby Biotech (Hong Kong) Co., Limited, Cordlife Technologies Pte. Ltd., CS Cell Technologies Pte. Ltd., Stemlife Berhad, and Shanghai Cordlife Biomedical Research Co., Ltd.